Pivotal Therapeutics Inc.
Not enough financial coverage to compute a composite score for PVTTF. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Companywww.pivotaltherapeutics.us
Pivotal Therapeutics Inc. , a specialty pharmaceutical company, focuses on the treatment of cardiovascular diseases and overall health. Its lead product, VASCAZEN, is a prescription only medical food formulated for clinical dietary management of cardiovascular disease in patients with documented coronary heart disease and who are deficient in blood Omega-3 fatty acids, eicosapentaenoic acid, and docosahexanenoic acid levels.
- CEO
- Rachelle MacSweeney
- IPO
- 2012
- HQ
- Woodbridge, ON, CA
Price Chart
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -79.54
- Avg Volume
- 0
Get TickerSpark's AI analysis on PVTTF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our PVTTF Coverage
We haven't published any research on PVTTF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PVTTF Report →